Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shabairunfei formula to prevent acute radiation pneumonitis
ChiCTR2300072148Phase 2Not yet recruiting
- Sponsor
- Shanxi Provincial Hospital of Traditional Chinese Medicine
- Start
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Shabairunfei in radiation pneumonitis (RP) (2 arms), sponsored by Shanxi Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Incident of acute radiation pneumonitis and Acute radiation lung injury RTOG classification. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
Shabairunfei
03
Conditions
radiation pneumonitis (RP)
Beyond the preview
Go deeper on ChiCTR2300072148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072148.